With one in six laboratory-confirmed bacterial infections worldwide already resistant to antibiotics, drug-resistant infections could contribute to more than 39 million deaths by 2050 if current trends persist, according to the World Health Organization (WHO).Speaking at the virtual 6th Annual Global Media Forum on AMR, WHO officials warned that countries are not doing enough to tackle antimicrobial resistance (AMR), despite growing commitments. They also presented findings from the latest joint survey by WHO, the United Nations Environment Programme, the World Organisation for Animal Health and the Food and Agriculture Organization.Although more countries have adopted national action plans to combat AMR, most have failed to translate these commitments into funded and implemented programmes. As a result, the world remains off track to meet key 2030 targets.Of the 183 countries surveyed, 173 reported having a national action plan, up from 79 in 2017. However, only 42 said their plans were financed and implemented.What Is Antimicrobial Resistance?Also read: Over One In Four Americans Lied To Get Antibiotics For Children: Why It Can Be DangerousAntimicrobial resistance occurs when bacteria, viruses, fungi and parasites evolve and no longer respond to medicines designed to treat them. This makes infections harder to treat and increases the risk of disease spread, severe illness and death.Antibiotic resistance is a form of AMR that specifically involves bacteria becoming resistant to antibiotics. Misuse and overuse of these medicines accelerate the problem.At the 2024 United Nations General Assembly, countries agreed on a series of targets to tackle AMR by 2030. However, experts warn that the growing threat could undermine decades of medical progress."Procedures we now take for granted become far riskier when antibiotics and antimicrobials no longer work," Jean-Pierre Nyemazi, acting director of WHO's AMR department, said. The development of new antibiotics is also failing to keep pace with the spread of resistance, he added, Reuters reported."Unlike COVID-19, which was very visible, drug-resistant infections have been taking people's lives for years without us noticing it and raising the alarm as we should," Nyemazi said at the forum.In 2021 alone, AMR was directly responsible for more than one million deaths and associated with approximately 4.7 million others, according to WHO figures.What Did The WHO Survey Show?The 2026 survey highlighted major gaps in infection prevention, a key measure for reducing the need for antibiotics.The WHO reported that 128 countries now have national infection prevention and control programmes and guidelines, up from 90 in 2018. However, only 69 countries, or 38%, have implemented these programmes nationwide, well below the 2030 target of 90%.Read More: 98 Years After Penicillin: Are We Running Out Of Effective Antibiotics?Laboratory capacity also remains limited. While 131 countries reported having national reference laboratories capable of testing antibiotic resistance in common bacteria, only 66 could test for both bacterial and fungal resistance. Countries have agreed to ensure that 80% have these capabilities by 2030.The WHO also released two toolkits to help countries strengthen diagnostic capacity, covering essential tests and laboratory procedures.Surveillance has improved, with 113 countries now monitoring antibiotic use and 109 tracking antimicrobial resistance, compared with 65 and 39, respectively, in 2017.However, only 21 countries reported integrating data on antibiotic use and resistance. The WHO said combining these datasets is essential to understand how antibiotic consumption drives resistance and to guide efforts to contain it.Why Is Taking Unnecessary Antibiotics Dangerous? Antibiotics treat bacterial infections but do not work against viral infections, which commonly cause cold- and flu-like symptoms. Unnecessary use can also expose patients to side effects and contribute to antimicrobial resistance.As per the WHO, resistance exists across 22 different antibiotics—the common drugs used to treat everyday illnesses, such as:Urinary tract infections (UTIs)Stomach and intestinal infectionsDangerous blood infectionsThe sexually transmitted disease gonorrhoeaWhen bacteria develop resistance, infections become harder to treat, increasing the risk of complications and limiting available treatment options.(With inputs from agencies)